METTL3 and acute myeloid leukemia: For example, STM2457, a small molecule inhibitor of METTL3 with in vivo activity, was shown to effectively disrupt the proliferation and expansion of leukemia cells, thereby inhibiting cancer progression in various mouse models of acute myeloid leukemia (Yankova et al. 2021).